يعرض 1 - 20 نتائج من 4,977 نتيجة بحث عن '(( c large decrease ) OR ((( a point decrease ) OR ( a marked decrease ))))', وقت الاستعلام: 0.43s تنقيح النتائج
  1. 1
  2. 2
  3. 3

    Cinacalcet administered early in the inactive phase markedly decrease parathyroid Ki-67 index. حسب Søren Egstrand (10906087)

    منشور في 2025
    "…<p>(A) Ki-67 expression in parathyroid glands of rats with CKD-induced sHPT treated with Cinacalcet either early in the inactive light phase (<i>Cina1</i>; N = 10) or early in the active dark phase (<i>Cina2</i>; N = 9) compared to untreated rats with sHPT investigated at similar time points (<i>PNX1</i>; N = 7 and <i>PNX2</i>; N = 7, respective) and to normal rats investigated at similar time points (<i>ctrl1</i>; N = 9 and <i>ctrl2</i>; N = 7, respective). …"
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15

    The Laboratory Animal Flow Diagram. حسب Xueqin lu (22250795)

    منشور في 2025
    "…Meanwhile, Kylo-0603 demonstrated a marked improvement in histological parameters, decreasing steatosis by up to 1.3 points (P < 0.001), inflammation by 1.8 points (P < 0.0001), and ballooning by 0.8 points (P < 0.01). …"
  16. 16

    <sup>1</sup>H NMR spectra for kylo-0603. حسب Xueqin lu (22250795)

    منشور في 2025
    "…Meanwhile, Kylo-0603 demonstrated a marked improvement in histological parameters, decreasing steatosis by up to 1.3 points (P < 0.001), inflammation by 1.8 points (P < 0.0001), and ballooning by 0.8 points (P < 0.01). …"
  17. 17

    <sup>13</sup>C NMR spectra for Kylo-0603. حسب Xueqin lu (22250795)

    منشور في 2025
    "…Meanwhile, Kylo-0603 demonstrated a marked improvement in histological parameters, decreasing steatosis by up to 1.3 points (P < 0.001), inflammation by 1.8 points (P < 0.0001), and ballooning by 0.8 points (P < 0.01). …"
  18. 18

    The structures of T3 and Kylo-0603. حسب Xueqin lu (22250795)

    منشور في 2025
    "…Meanwhile, Kylo-0603 demonstrated a marked improvement in histological parameters, decreasing steatosis by up to 1.3 points (P < 0.001), inflammation by 1.8 points (P < 0.0001), and ballooning by 0.8 points (P < 0.01). …"
  19. 19

    Synthesis process of Kylo-0603. حسب Xueqin lu (22250795)

    منشور في 2025
    "…Meanwhile, Kylo-0603 demonstrated a marked improvement in histological parameters, decreasing steatosis by up to 1.3 points (P < 0.001), inflammation by 1.8 points (P < 0.0001), and ballooning by 0.8 points (P < 0.01). …"
  20. 20

    ESI-HRMS spectra for Kylo-0603. حسب Xueqin lu (22250795)

    منشور في 2025
    "…Meanwhile, Kylo-0603 demonstrated a marked improvement in histological parameters, decreasing steatosis by up to 1.3 points (P < 0.001), inflammation by 1.8 points (P < 0.0001), and ballooning by 0.8 points (P < 0.01). …"